GRIFFIN MURRAY: Open Payments
NPI 1003540709 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,116 in 101 payments from 28 companies in 2025. Trend: 2023 $2,896 · 2024 $2,772 · 2025 $2,116
Food & beverage: $2,116
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $348 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $203 |
| Lilly USA, LLC | 10 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $154 |
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| PFIZER INC. | 7 | $138 |
| ABBVIE INC. | 5 | $131 |
| ALK-Abello, Inc | 6 | $125 |
| Exact Sciences Corporation | 7 | $123 |
| GlaxoSmithKline, LLC. | 4 | $62 |
Products named: XIFAXAN, Wegovy, CAPLYTA, MOUNJARO, Odactra, Ozempic, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across NY — which companies pay providers there.
